Peterson Wealth Services grew its position in HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 35,985.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 7,217 shares of the company’s stock after buying an additional 7,197 shares during the quarter. Peterson Wealth Services’ holdings in HealthEquity were worth $661,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors also recently made changes to their positions in HQY. William Blair Investment Management LLC acquired a new position in shares of HealthEquity in the fourth quarter worth about $169,956,000. Norges Bank acquired a new position in shares of HealthEquity in the fourth quarter worth about $66,927,000. AQR Capital Management LLC boosted its holdings in shares of HealthEquity by 148.5% in the second quarter. AQR Capital Management LLC now owns 1,107,448 shares of the company’s stock worth $116,016,000 after buying an additional 661,795 shares during the period. Northwestern Mutual Wealth Management Co. boosted its holdings in shares of HealthEquity by 229,985.6% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 478,578 shares of the company’s stock worth $43,843,000 after buying an additional 478,370 shares during the period. Finally, Westfield Capital Management Co. LP boosted its holdings in shares of HealthEquity by 35.7% in the third quarter. Westfield Capital Management Co. LP now owns 1,716,658 shares of the company’s stock worth $162,688,000 after buying an additional 451,450 shares during the period. 99.55% of the stock is currently owned by institutional investors and hedge funds.
HealthEquity Stock Performance
HQY stock opened at $88.96 on Friday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 3.44 and a current ratio of 3.44. The stock has a market cap of $7.44 billion, a P/E ratio of 33.32, a P/E/G ratio of 1.51 and a beta of 0.21. The firm has a 50 day simple moving average of $84.54 and a 200 day simple moving average of $85.86. HealthEquity, Inc. has a 52 week low of $72.76 and a 52 week high of $106.60.
Analyst Ratings Changes
Several research analysts have commented on the stock. Barrington Research reiterated an “outperform” rating and issued a $110.00 target price on shares of HealthEquity in a report on Friday, May 22nd. Citizens Jmp raised their target price on HealthEquity from $110.00 to $111.00 and gave the stock a “market outperform” rating in a research report on Monday, June 1st. Citigroup reaffirmed a “market outperform” rating on shares of HealthEquity in a research report on Monday, June 1st. Royal Bank Of Canada raised their target price on HealthEquity from $100.00 to $108.00 and gave the stock an “outperform” rating in a research report on Wednesday, June 3rd. Finally, Deutsche Bank Aktiengesellschaft raised their target price on HealthEquity from $120.00 to $128.00 and gave the stock a “buy” rating in a research report on Thursday, March 19th. One investment analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, HealthEquity currently has a consensus rating of “Moderate Buy” and an average price target of $110.57.
Read Our Latest Stock Report on HQY
Insider Buying and Selling at HealthEquity
In other HealthEquity news, Director Gayle Furgurson Wellborn sold 2,439 shares of the business’s stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $219,510.00. Following the transaction, the director owned 19,733 shares in the company, valued at $1,775,970. The trade was a 11.00% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Michael Henry Fiore sold 3,142 shares of the business’s stock in a transaction dated Friday, May 29th. The shares were sold at an average price of $95.00, for a total value of $298,490.00. Following the completion of the transaction, the executive vice president owned 59,113 shares in the company, valued at $5,615,735. This trade represents a 5.05% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 13,081 shares of company stock worth $1,193,000 over the last 90 days. 1.60% of the stock is currently owned by corporate insiders.
HealthEquity Company Profile
HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.
Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.
Recommended Stories
- Five stocks we like better than HealthEquity
- Microsoft Just Gave Investors 3 Dates They Can’t Afford to Ignore
- NVIDIA’s Outlook Gains Momentum: Stock Price to Follow
- The World Cup Is Coming—These 3 Stocks Could Cash In
- Spotify’s “North Star” Outlook Was Music to Investors Ears
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY – Free Report).
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.
